【ChiCTR2500110542】A Comparative study between Induction Chemotherapy Followed by Concurrent Chemoradiation versus Concurrent Chemoradiation in the Management of Locally Advanced Uterine Cervical Cancer
ChiCTR2500110542
尚未开始
/
/
/
2025-10-15
/
/
Cancer cervix
A Comparative study between Induction Chemotherapy Followed by Concurrent Chemoradiation versus Concurrent Chemoradiation in the Management of Locally Advanced Uterine Cervical Cancer
A Comparative study between Induction Chemotherapy Followed by Concurrent Chemoradiation versus Concurrent Chemoradiation in the Management of Locally Advanced Uterine Cervical Cancer
This study aims to explore the efficacy and tolerability of induction chemotherapy followed by chemoradiation versus conventional therapy chemoradiation in patients with locally advanced uterine cervical cancer.
随机平行对照
Ⅲ期
Randomization will be performed using a computer-generated random number table
Open-label
Sohag university
/
40
/
2025-10-12
2027-10-12
/
1.Age between 18 and 70 years; 2.Clinically staged as IB3–IVA according to the International Federation of Gynecology and Obstetrics (FIGO); 3.Histologically proved squamous cell carcinoma or adenocarcinoma of the uterine cervix; 4.Performance status 0–2 according to Word Health Organization (WHO) criteria; 5.Normal hematological, renal and hepatic function.；
请登录查看1.Severe systemic or uncontrolled disease (infection, central nervous system, metabolic, etc.) that precluded the use of chemotherapy; 2.Pre-existing high grade neuropathy of any cause; 3.Histologically proved small cell carcinoma, leiomyosarcoma, lymphoma and other histopathologies other than Squamous cell carcinoma & adenocarcinoma; 4.Mental illness; 5.Previous or concomitant malignancies.；
请登录查看Sohag university
/
Sohag university的其他临床试验
- Evaluation of blood and nerve functions among household contacts of leprosy patients in Sohag governorate
- Maintenance Venetoclax Based Therapy Post Complete Remission In AML Fit Patients
- A Comparative study between Induction Chemotherapy Followed by Concurrent Chemoradiation versus Concurrent Chemoradiation in the Management of Locally Advanced Uterine Cervical Cancer
Sohag university的其他临床试验
- Evaluation of blood and nerve functions among household contacts of leprosy patients in Sohag governorate
- Maintenance Venetoclax Based Therapy Post Complete Remission In AML Fit Patients
- A Comparative study between Induction Chemotherapy Followed by Concurrent Chemoradiation versus Concurrent Chemoradiation in the Management of Locally Advanced Uterine Cervical Cancer
- THE OUTCOME OF MULTIDISCIPLINARY MANAGEMENT OF CAROTID BODY TUMORS: A RETROSPECTIVE COHORT STUDY
最新临床资讯
-
一项5年临床安全随访研究启示：#脐带间充质干细胞（#hUC-MSCs）
SCLnow圣释2026-11-11
-
SYNCHRONIZE-CVOT试验达到主要终点，索弗度肽（survodutide）成为全球首个证实心血管安全性的胰高血糖素/GLP-1双受体激动剂
勃林格殷格翰中国2026-11-11
-
医药观澜2026-11-11
-
宜明昂科2026-11-11
-
医学科学院精准医学研究所2026-11-11
-
多肽圈2026-11-11
-
多肽圈2026-11-11
-
求是网2026-11-11
-
干细胞之父2026-11-11
-
和田维药2026-11-11
全球药物研发中心
全球研发数据与行业前沿情报
研发动态
相关报告
政策法规
-
2026-11-12
-
2026-11-12
-
2026-11-12
-
摩熵咨询 20 3
-
摩熵咨询 33 62
-
摩熵咨询 20 3
-
颁布机构：国家卫生健康委办公厅、 2026-11-10
-
颁布机构：国家卫健委（原国家卫计委） 2026-11-10
-
颁布机构：国家药品审评中心（CDE） 2026-10-16
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
市场动态
市场报告
政策法规
-
2026-11-11
-
2026-11-11
-
2026-11-11
-
摩熵咨询 35 92
-
摩熵咨询 28 74
-
摩熵咨询 34 49
-
颁布机构：国家市场监督管理总局 2026-11-07
-
颁布机构：国家市场监督管理总局 2026-11-07
-
颁布机构：国家市场监督管理总局 2026-11-04